Newborn Jaundice and Kernicterus: When Delayed Treatment Can Cause Brain Damage

Newborn jaundice is common, but dangerously high bilirubin levels can cause permanent brain damage if medical providers fail to recognize and treat the condition promptly. In severe cases, untreated hyperbilirubinemia can lead to kernicterus, a form of bilirubin-related brain injury that can cause lifelong neurological disabilities.

Most newborns with jaundice recover without lasting harm. The critical issue is whether healthcare providers monitor bilirubin levels appropriately, recognize when those levels require treatment, and act quickly when a baby faces a risk of serious complications. Delayed testing, inadequate follow-up, or failure to escalate treatment can allow a preventable medical emergency to develop.

For families whose children suffer neurological injuries after birth, understanding how jaundice should be assessed and treated can help clarify whether medical negligence played a role. Kalfayan Merjanian, LLP represents California families in serious birth injury malpractice cases and helps investigate whether failures in newborn care contributed to preventable harm.

What Causes Newborn Jaundice, and When Does It Become Dangerous?

Jaundice causes a baby’s skin and the whites of the eyes to appear yellow. It develops when bilirubin, a yellow substance produced as the body breaks down red blood cells, accumulates in the blood.

Newborns are particularly susceptible because their bodies process bilirubin differently from those of older children and adults. Their red blood cells turn over relatively quickly, and their livers may not yet be efficient at removing bilirubin. As a result, bilirubin levels commonly rise during the first several days after birth.

In many babies, this process is temporary and resolves with appropriate feeding, monitoring, and, when necessary, treatment. However, bilirubin levels can become dangerously high, particularly when a baby has certain medical conditions or risk factors.

Severe hyperbilirubinemia can allow bilirubin to enter the brain and damage vulnerable brain tissue. This risk makes timely assessment important, especially when jaundice appears early, bilirubin levels rise rapidly, or a newborn has difficulty feeding or shows unusual behavior.

The presence of visible jaundice alone does not establish that a baby is in danger. Providers must assess the baby’s age in hours, bilirubin level, gestational age, and relevant risk factors to determine whether treatment is needed.

How Should Healthcare Providers Monitor Bilirubin Levels?

Bilirubin monitoring helps providers identify newborns who need closer observation or treatment before levels become dangerous. Assessment typically involves checking for visible jaundice and measuring bilirubin using a skin-based device or a blood test. A blood test may be needed to confirm a screening result or guide treatment decisions.

The timing of testing matters. Bilirubin levels can change significantly during the first days of life, and a measurement that is reassuring at one point does not necessarily mean the baby will remain safe later. Providers must interpret results in relation to the newborn’s age in hours and the applicable treatment thresholds.

Current clinical guidance also emphasizes assessing risk factors for developing significant hyperbilirubinemia and the risk of bilirubin-related brain injury. These factors can include prematurity, certain blood group incompatibilities, hemolysis (the accelerated breakdown of red blood cells), sepsis, and clinical instability.

Before discharge, providers should determine whether the baby’s bilirubin level requires treatment or follow-up and arrange appropriate reassessment when necessary. Parents should receive clear instructions about when the baby needs another bilirubin measurement, what feeding and diaper patterns to monitor, and which symptoms require urgent medical attention.

A failure to measure bilirubin when indicated, misinterpret a result, or arrange timely follow-up can allow a developing problem to go undetected.

What Is Phototherapy, and When Should It Begin?

Phototherapy is a standard treatment for newborns whose bilirubin levels reach the applicable treatment threshold. It uses specific wavelengths of light to change bilirubin into forms the baby’s body can eliminate more easily.

During treatment, the baby is exposed to therapeutic light, with eye protection and other precautions as appropriate. Providers monitor bilirubin levels to determine whether treatment is working and whether additional intervention is necessary. Feeding, hydration, temperature, and the baby’s overall condition also require attention.

The decision to begin phototherapy depends on several factors, including the baby’s age in hours, gestational age, bilirubin level, and risk factors for bilirubin neurotoxicity. There is no single bilirubin number that applies to every newborn.

When treatment is indicated, an unjustified delay can allow bilirubin levels to continue rising. In some cases, a baby may need phototherapy while still in the hospital; in others, carefully arranged outpatient treatment and follow-up may be appropriate. The clinical circumstances determine the safest approach.

Phototherapy is generally effective, but it does not eliminate the need for monitoring. Providers must reassess bilirubin levels and recognize when a baby is not responding as expected or is approaching a more dangerous threshold.

When Must Treatment Be Escalated?

Some newborns develop bilirubin levels that remain dangerously high or rise despite phototherapy. When bilirubin approaches the threshold at which exchange transfusion is recommended, the situation becomes a medical emergency requiring prompt escalation.

Escalation-of-care protocols generally require intensive monitoring, urgent medical evaluation, intensive phototherapy, hydration when indicated, and preparation for possible exchange transfusion. The exact steps depend on the baby’s condition and applicable clinical guidance.

An exchange transfusion is a procedure in which a baby’s blood is replaced in controlled portions with compatible donor blood. It can rapidly lower bilirubin and address certain underlying blood-related problems. Because the procedure carries risks, it is reserved for situations in which the expected benefits justify those risks.

Providers must also look for signs of acute bilirubin encephalopathy, an evolving neurological condition associated with bilirubin toxicity. Symptoms can include unusual sleepiness, poor feeding, abnormal muscle tone, a high-pitched cry, arching of the neck or body, and changes in alertness. Severe cases can progress to seizures, coma, or death.

When these signs appear, waiting for routine follow-up or relying on a previous bilirubin result can be dangerous. The medical team must recognize the potential emergency and act promptly.

What Is Kernicterus, and How Can It Affect a Child for Life?

Kernicterus refers to chronic brain injury caused by bilirubin toxicity. It can develop when dangerously high bilirubin levels are not adequately controlled and bilirubin damages specific areas of the developing brain.

The consequences vary, but affected children can experience permanent neurological impairments. These may include:

• Movement disorders: Abnormal muscle tone, involuntary movements, or a form of cerebral palsy associated with bilirubin injury.
• Hearing impairment: Auditory neuropathy or other hearing problems that interfere with the ability to process sound and develop speech.
• Vision and gaze difficulties: Problems controlling eye movements or directing the eyes normally.
• Developmental and communication challenges: Difficulties with speech, coordination, learning, or other developmental skills, depending on the extent of injury.

Some children require ongoing physical, occupational, and speech therapy. Others may need hearing devices, specialized education, assistive equipment, or help with daily activities. Severe injuries can require lifelong care.

Kernicterus is not inevitable whenever a newborn develops jaundice. Most jaundiced babies do not develop this condition. The concern is whether bilirubin reached dangerous levels and whether appropriate monitoring and treatment could have prevented the resulting injury.

When Can Delayed Treatment for Jaundice Constitute Medical Negligence?

A poor outcome alone does not establish medical malpractice. Newborn jaundice can develop rapidly, and some babies have medical conditions that make treatment more complicated. A malpractice claim requires evidence that a healthcare provider failed to meet the applicable standard of care and that the failure caused or contributed to the child’s injury.

Potential concerns include failing to measure bilirubin when indicated, overlooking a concerning result, delaying phototherapy, discharging a baby without appropriate follow-up arrangements, or failing to escalate care when bilirubin levels approach dangerous thresholds.

Communication failures can also matter. For example, a provider may obtain a concerning result but fail to communicate it promptly to the clinician responsible for treatment. A family may receive unclear discharge instructions or be told to return for testing without a reliable plan to ensure follow-up occurs.

Consider a newborn whose bilirubin level is rising and who has risk factors for severe hyperbilirubinemia. If the medical team fails to arrange a timely repeat measurement or begin indicated treatment, the level could rise into a dangerous range before the baby receives care. If the child later develops kernicterus, a medical investigation may need to determine whether earlier action would likely have prevented or reduced the injury.

The evaluation depends on the records, the baby’s clinical condition, the timing of decisions, and expert analysis. Not every delay causes brain damage, and not every case of kernicterus results from negligent care. The evidence must connect the alleged failure to the harm.

What Evidence Can Help Establish Whether a Newborn Was Properly Treated?

A birth injury investigation often begins with a detailed timeline of bilirubin measurements, feeding, symptoms, medical decisions, and treatment. Small gaps in that timeline can be important when determining whether providers recognized a worsening condition and responded appropriately.

Relevant records may include newborn examinations, bilirubin screening results, laboratory tests, feeding and weight records, nursing notes, phototherapy documentation, discharge instructions, follow-up appointments, and communications among healthcare providers. If the baby required intensive care, records of neurological assessments, hearing evaluations, seizures, and other complications may help establish the nature of the injury.

Medical experts can evaluate whether testing and treatment were timely, whether the baby’s bilirubin levels crossed relevant treatment thresholds, and whether the clinical team should have escalated care sooner. Pediatric neurologists, neonatologists, and other qualified specialists may help assess the cause and long-term consequences of the injury.

Families can help preserve evidence by requesting copies of available medical records, keeping discharge paperwork and follow-up instructions, and documenting concerns they raised about feeding, alertness, or changes in the baby’s condition. An attorney can help obtain complete records and coordinate an independent review.

What Compensation Is Available for a Child Injured by Kernicterus?

When medical negligence causes permanent neurological injury, the financial consequences can extend throughout the child’s life. A claim may seek compensation for past and future medical care, specialist visits, therapies, hearing services, medications, assistive technology, and other services related to the injury.

Some children need substantial support with mobility, communication, personal care, or daily living. Others require specialized education and adaptations at home. A comprehensive assessment should consider both the services the child needs now and those likely to be necessary as the child grows into adulthood.

Future care needs can be evaluated with help from medical professionals and life care planning experts. Economic experts can help estimate the long-term cost of treatment and support. The goal is to build a realistic picture of the resources required rather than relying only on expenses already incurred.

California medical malpractice claims are subject to special legal rules, including limits on certain damages and deadlines that can depend on the circumstances. Cases involving children have additional timing considerations. Families should seek legal advice promptly rather than assume that they can wait until a child reaches a particular age.

How Can Kalfayan Merjanian, LLP Help With a Newborn Jaundice Birth Injury Case?

When a child develops kernicterus or another serious injury associated with elevated bilirubin, parents deserve answers about how the condition was monitored and treated. Determining whether the injury could have been prevented often requires a careful review of bilirubin results, treatment decisions, discharge planning, and the child’s subsequent medical course.

Kalfayan Merjanian, LLP helps California families pursue potential birth injury and medical malpractice claims. The firm can work with qualified medical experts to evaluate whether delayed testing, inadequate monitoring, or failure to escalate treatment contributed to a child’s injury and to assess the long-term care and financial needs that may follow.

If your child suffered brain damage, hearing loss, or other serious complications after newborn jaundice, contact Kalfayan Merjanian, LLP to discuss your concerns and understand your family’s legal options. A thorough investigation can help clarify what happened and whether preventable medical errors played a role in your child’s future.